Bioptimus

Bioptimus builds universal AI foundation models for biology, turning multiscale biological data - from molecules to entire organisms - into insights for research and clinical use. The company's technical work spans foundation models, machine learning and digital pathology, with a stated mission of breaking down silos between biological datasets to enable breakthrough discoveries in biomedicine.

Its flagship model, H-Optimus, is a foundation model for digital pathology and ranks #1 out of 22 foundation models in that domain. The wider family of Bioptimus foundation models is used by researchers and clinicians and is on track to reach 1 million downloads; roughly 100 scientific publications per year use the company's models. Training has drawn on 2 billion images, sourced from over 4,000 contributing clinical practices.

Bioptimus has raised $76 million in funding. The company operates at the intersection of biotechnology, pharmaceuticals and drug discovery, clinical trials, healthcare and clinical diagnostics, and biomedical research. Its culture signals a strong academic and scientific adoption focus, with work oriented towards research outcomes as well as clinical application.